Is astute moneyman Andrew Kroger a buyer of CTE shares...or a seller?
Right now, he controls 40% of the capital. He had the option of building beyond 50% when second-ranking shareholder Cell Care decided to sell. But he chose not to.
He has another option - to faciliate a takeover by selling his stake to private equity or other acquisitive interests.
If he was to do that, I'd suggest he'd be wanting at least a $1 per share.
Clearly, Cryosite is emerging as a pivotal clinical trials and cold chain logistics player. It has intriguing prospects.
- Forums
- ASX - By Stock
- Ann: Becoming a substantial holder
Is astute moneyman Andrew Kroger a buyer of CTE shares...or a...
Featured News
Add CTE (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.85M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CTE (ASX) Chart |
Day chart unavailable